Rosalia I Cordo Russo - National Scientific and Technical Research Council

基本信息

浏览量：1

职业迁徙

个人简介

Rosalia I Cordo Russo currently works at the IBYME - Instituto de Biologia y Medicina Experimental, National Scientific and Technical Research Council. Rosalia does research in Cancer Research. Their current project is " Breast Cancer'.

研究兴趣

论文共 42 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PO2-18-05: Blocking Soluble TNF to Improve Potency of Trastuzumab Deruxtecan by Increasing Internalization and Antitumor Innate Immune Response in a Resistant HER2-positive Breast Cancer Model

Sofia Bruni,Florencia Mauro,Sofia Naveiro,Rosalia Cordo-Russo,Agustina Dupont,Mercogliano María Florencia,Roxana Schillaci

Cancer Researchno. 9_Supplement (2024): PO2-18

引用0浏览0引用

Abstract 2753: Muc4 is a biomarker of metastasis in TNBC and its downregulation by blocking soluble TNF prevents metastasis in combination with immunotherapy

Florencia Luciana Mauro,Sofia Bruni,Agustina Dupont,Gloria Inurrigarro,Silvina Figurelli,Sabrina Barchuk,Daniel Lopez Della Vecchia,Rosalia Cordo Russo,Ernesto Gil Deza,Maria Florencia Mercogliano,Roxana Schillaci

Cancer Researchno. 6_Supplement (2024): 2753-2753

引用0浏览0引用

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 (vol 35, pg 6189, 2016)

L. Venturutti,R. I. Cordo Russo,M. A. Rivas,M. F. Mercogliano,F. Izzo,R. H. Oakley,M. G. Pereyra,M. De Martino,C. J. Proietti,P. Yankilevich,J. C. Roa,P. Guzman, E. Cortese, D. H. Allemand, T. H. Huang,E. H. Charreau,J. A. Cidlowski,R. Schillaci,P. V. Elizalde

ONCOGENE (2023)

引用0浏览0引用

New Therapeutic Approach for Triple Negative Breast Cancer: Soluble TNFα Blockade and MUC4 Expression As a Prognostic Biomarker

Florencia Mauro,Sofia Bruni,Agustina Dupont,Gloria Inurrigarro,Silvina Figurelli,Sabrina Barchuk,Daniel Lopez Della Vecchia,Rosalia Cordo Russo,Ernesto Gil Deza,Maria Florencia Mercogliano,Roxana Schillaci

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

MiR-16 Mediates Trastuzumab and Lapatinib Response in ErbB-2-positive Breast and Gastric Cancer Via Its Novel Targets CCNJ and FUBP1

L Venturutti,R I Cordo Russo,M A Rivas,M F Mercogliano,F Izzo,R H Oakley,M G Pereyra,M De Martino,C J Proietti,P Yankilevich,J C Roa,P Guzmán, E Cortese, D H Allemand, T H Huang,E H Charreau,J A Cidlowski,R Schillaci,P V Elizalde

Oncogeneno. 50 (2023): 3719-3719

引用72浏览0WOSNATURE引用

Cancer immune exclusion: breaking the barricade for a successful immunotherapy

Sofia Bruni,María Florencia Mercogliano,Florencia Luciana Mauro,Rosalia Inés Cordo Russo,Roxana Schillaci

Frontiers in oncology (2023): 1135456

引用2浏览0WOS引用

Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance (vol 34, pg 3413, 2015)

R. I. Cordo Russo,W. Beguelin,M. C. Diaz Flaque,C. J. Proietti,L. Venturutti,N. Galigniana,M. Tkach,P. Guzman,J. C. Roa,N. A. O'Brien,E. H. Charreau,R. Schillaci,P. V. Elizalde

ONCOGENE (2023)

引用0浏览0引用

Targeting Erbb-2 Nuclear Localization and Function Inhibits Breast Cancer Growth and Overcomes Trastuzumab Resistance

R I Cordo Russo,W Béguelin,M C Díaz Flaqué,C J Proietti,L Venturutti,N Galigniana,M Tkach,P Guzmán,J C Roa,N A O'Brien,E H Charreau,R Schillaci,P V Elizalde

Oncogene（2023）

引用42浏览0WOSNATURE引用

RETRACTION: Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy (Retraction of Vol 15, art no R118, 2013)

Maria C. Diaz Flaque,Natalia M. Galigniana,Wendy Beguelin,Rocio Vicario,Cecilia J. Proietti,Rosalia Cordo Russo,Martin A. Rivas,Mercedes Tkach,Pablo Guzman,Juan C. Roa,Esteban Maronna,Viviana Pineda,Sergio Munoz,Maria Florencia Mercogliano,Eduardo H. Charreau,Patricio Yankilevich,Roxana Schillaci,Patricia V. Elizalde

BREAST CANCER RESEARCHno. 1 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn